| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
chromosome 3 open reading frame 62 | 1.3E-04 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||||
|
cAMP responsive element binding protein 3 like 2 | 0.691 | 0.115 | 1.5E-03 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2004 | 2006 | ||||||||
|
src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites | 0.805 | 0.154 | 1.3E-12 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
NK2 homeobox 2 | 0.678 | 0.269 | 0.41 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
SSX family member 1 | 0.674 | 0.308 | 3.7E-45 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1997 | 1997 | ||||||||
|
MAGE family member A4 | 0.653 | 0.346 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
salt inducible kinase 1B (putative) | 0.653 | 0.385 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
ETS variant transcription factor 1 | 0.631 | 0.385 | 0.94 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1997 | 1997 | ||||||||
|
PR/SET domain 10 | 0.760 | 0.385 | 0.15 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
testis specific 10 | 0.674 | 0.385 | 0.11 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
SS18 subunit of BAF chromatin remodeling complex | 0.641 | 0.462 | 0.75 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 1997 | 2006 | ||||||||
|
double homeobox 4 | 0.604 | 0.500 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2014 | |||||||||
|
ETS variant transcription factor 4 | 0.545 | 0.500 | 2.9E-08 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
claudin 6 | 0.656 | 0.500 | 4.0E-03 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
paired box 7 | 0.597 | 0.538 | 0.14 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1997 | 1997 | ||||||||
|
ASPSCR1 tether for SLC2A4, UBX domain containing | 0.653 | 0.538 | 4.4E-12 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
transient erythroblastopenia of childhood | 0.659 | 0.577 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1997 | 1997 | |||||||||
|
insulin like growth factor 2 mRNA binding protein 3 | 0.570 | 0.577 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
fibroblast growth factor 4 | 0.588 | 0.577 | 0.14 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
SSX family member 2B | 0.599 | 0.577 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | |||||||||
|
NGFI-A binding protein 2 | 0.641 | 0.577 | 0.57 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
SSX family member 2 | 0.581 | 0.615 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2005 | 2006 | |||||||||
|
trafficking from ER to golgi regulator | 0.595 | 0.615 | 0.14 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
insulin like growth factor 2 mRNA binding protein 2 | 0.588 | 0.615 | 0.24 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
dentin matrix acidic phosphoprotein 1 | 0.556 | 0.615 | 1.5E-07 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 |